ARCHIVES

PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval.

This article is from The Cancer Letter archive.

Vol. 34 No. 08 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

March 11, 2005

ASCO To Include Chernobyl Talk, Educational sessions

May 1, 1987

Obituary: NCI’s Elaine Ron, Expert in Radiation Heath Effects

December 3, 2010

FDA Describes Meeting With NCI In “Limited” Memo

May 7, 1976

NCI Exceeded Mandate In Study Of Legislators, Rep. Porter Says

August 11, 1995

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993